Breast cancer in 2014: A call back to reality! (Q38308031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

review article

1 reference

title

Breast cancer in 2014: A call back to reality! (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1

Fatima Cardoso

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

2 September 2017

Elżbieta Senkus-Konefka

series ordinal

2

object named as

Elżbieta Senkus

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

2 September 2017

language of work or name

English

0 references

publication date

6 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

67-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

The 41st David A. Karnofsky Memorial Award Lecture: Academic research worldwide--quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.226

10.1038/NRCLINONC.2014.226

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25560532%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference